Detalhe da pesquisa
1.
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.
Nature
; 559(7714): 363-369, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29950727
2.
The molecular underpinnings of prostate cancer: impacts on management and pathology practice.
J Pathol
; 241(2): 173-182, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27753448
3.
The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells.
Nat Cancer
; 4(8): 1102-1121, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37460872
4.
CD38 in Advanced Prostate Cancers.
Eur Urol
; 79(6): 736-746, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33678520
5.
Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA.
Eur Urol
; 80(2): 243-253, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34103179
6.
HER3 Is an Actionable Target in Advanced Prostate Cancer.
Cancer Res
; 81(24): 6207-6218, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753775
7.
Genomics of lethal prostate cancer at diagnosis and castration resistance.
J Clin Invest
; 130(4): 1743-1751, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31874108
8.
Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer.
Eur Urol
; 76(4): 469-478, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345636
9.
Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency.
Eur Urol
; 75(1): 184-192, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30340782
10.
RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 25(2): 687-697, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30257982
11.
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer.
Eur Urol
; 76(5): 676-685, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036442
12.
Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future Promise.
Cold Spring Harb Perspect Med
; 8(6)2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29101113
13.
Hypoxia and Noncoding RNAs in Taxane Resistance.
Trends Pharmacol Sci
; 39(8): 695-709, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29891252
14.
Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA).
Eur Urol
; 74(3): 283-291, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29500065
15.
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers.
Eur Urol Oncol
; 1(1): 71-77, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29911685
16.
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.
PLoS One
; 13(3): e0193689, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29494651
17.
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.
Eur Urol Oncol
; 1(2): 151-159, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31100240
18.
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC).
Clin Cancer Res
; 24(13): 3149-3162, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29555663
19.
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity.
Clin Cancer Res
; 24(22): 5585-5593, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30068710
20.
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer.
Cell Rep
; 22(3): 796-808, 2018 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29346775